
A failed first startup taught Evan Kervella to rebuild his circumstances. Now he is pairing quantum sensors, software and patient hardware in a long campaign to make MRI easier to place where people already receive care.
Johannes Galatsanos is Co-Founder and CEO of Diffraqtion, a Boston-based quantum imaging startup that has built a quantum camera capable of recovering 95% of photon information lost by conventional sensors - translating to 20x higher resolution and 1,000x faster image processing than any existing optical system. A multilingual MIT and Oxford graduate with Greek-German roots, Galatsanos pivoted from leading AI and data transformation at Novartis to commercializing a decade of DARPA- and NASA-backed quantum photonics research. Diffraqtion won first prize at SLUSH 2025, secured a $4.2M pre-seed round in January 2026, and is targeting satellite launches for space domain awareness and Earth observation by 2028-2029.
Matt Goldman is a General Partner at J2 Ventures, a Boston-based early-stage VC firm backing dual-use technologies at the intersection of commercial markets and U.S. national security. A retired U.S. Air Force Colonel with 22+ years of service, he served as the founding Chief Medical Officer of the Defense Innovation Unit (DIU), bridging commercial innovation with defense applications. Simultaneously, he is a practicing pediatric gastroenterologist and Clinical Assistant Professor at Stanford Children's Health - an almost singular combination of MD, military officer, and venture capitalist. J2 Ventures has raised three funds totaling $468M+ and backed 35+ startups including two unicorns: Oura and Apex Space.